Thrive365 received $835,000 funding from the investors in an equity round according to the SEC file registered.
San Francisco-based Welkin Health, which which specializes in patient relationship management through messaging services and workflow organization, has raised $8 million in a new round led by Thrive Capital. This brings Welkin’s total funding to $12 million. San Francisco-based Welkin Health, which which specializes in patient relationship management through messaging services and workflow organization, has raised $8 million in a new round led by Thrive Capital. This brings Welkin’s total funding to $12 million.
Zürich, Switzerland-based Oviva Health, developer of a dietary intervention delivery platform, has secured $12 million in Series A funding. Participants in the round include Albion Capital, Eight Roads Ventures, F-Prime Capital Partners, Partech Ventures, and Walking Ventures.
The K'Watch project is rewarded as the winner of the Digital Innovation Contest (Concours Innovation Numérique or CIN in French) organized by the Public Investment Bank (Bpifrance). Bpifrance finances PKvitality with more than €1 million, a mix of grant and loan. This allows us to fund the development of the project over the coming months.
Mumbai-based Wellthy Therapeutics Pvt Ltd, which operates a mobile-based diabetes management platform, has raised an undisclosed sum from early-stage investor GrowX Ventures, a person directly in the know told VCCircle.
Artificial pancreas startup Beta Bionics has secured the first slice of a planned $25 million financing round. The announcement of the round's first $2.5 million comes six months after midphase data positioned Beta Bionics to look forward to a pivotal trial of its diabetes device.
Onalabs Inno-Hub S.L. has achieved that its project ONALABS is one of the projects that will receive funds from the European Commission in the framework programme of R&D Horizon 2020, in the sub-programme SME instrument, H2020-SMEINST-1-2016-2017
Hygieia received $835,000 funding in a debt financing round according to the SEC file registered.
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced the closing of its previously announced underwritten public offering of 30 million shares of common stock at a price to the public of $2.00 per share. In addition, the underwriters fully exercised an option to purchase 4.5 million additional shares of common stock at the public offering price. All of the shares in the offering were offered by Tandem, with gross proceeds to Tandem of $69 million from the offering of an aggregate of 34.5 million shares.
Digital therapeutics firm Wellthy Therapeutics has raised Rs 13.5 crore ($2.1 million) from Ranjan Pai’s family office Manipal Education & Medical Group (MEMG) family office LLP along with Apoorva Patniled Currae Healthtech Fund, Singapore-based Beenext Ventures, GrowX Ventures, IIFL Select Equity Fund amongst other individual investors. The Mumbai-based firm that plays into digital therapeutics, enables treatment of type-II diabetes using a hybrid of AI and human paramedical coaches to improve health literacy and facilitate behaviour change for better outcomes in patients.